Recent data have suggested a key role for tumor necrosis factor (TNF)-
alpha in the insulin resistance of obesity and non-insulin-dependent d
iabetes mellitus (NIDDM). TNF-alpha expression is elevated in the adip
ose tissue of multiple experimental models of obesity. Neutralization
of TNF-alpha in one of these models improves insulin sensitivity by in
creasing the activity of the insulin receptor tyrosine kinase, specifi
cally in muscle and fat tissues. On a cellular level, TNF-alpha is a p
otent inhibitor of the insulin-stimulated tyrosine phosphorylations on
the beta-chain of the insulin receptor and insulin receptor substrate
-1, suggesting a defect at or near the tyrosine kinase activity of the
insulin receptor. Given the clear link between obesity, insulin resis
tance, and diabetes, these results strongly suggest that TNF-alpha may
play a crucial role in the systemic insulin resistance of NIDDM. This
may allow for new treatments of disorders involving resistance to ins
ulin.